Trade Summary

5 days ago, Reed John C, serving as EVP, Innovative Medicine, R, D at Johnson & Johnson (JNJ), sold 53,931 shares at $243.00 per share, for a total transaction value of $13,105,233.00. Following this transaction, Reed John C now holds 10,658 shares of JNJ.

This sale represents a 83.00% decrease in Reed John C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, 1 day after the trade was made.

Johnson & Johnson operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.